FDA Orange Book · active-ingredient family
Methyldopa
Methyldopa is approved as 3 brand and 43 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ALDOMET · NDA 013400
3
Brand (NDA)
43
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · suspension, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ALDOMETRLD×3 | MERCK | NDA 013400 | — | Approved Prior to Jan 1, 1982 | |
| METHYLDOPA×2 | CHARTWELL RX | NDA 018934 | — | Jun 29, 1984 | |
| ALDOMET | MERCK | NDA 018389 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (43)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| METHYLDOPA | SUPERPHARM | ANDA 070669 | — | Jun 23, 1989 | |
| METHYLDOPA | SUPERPHARM | ANDA 070670 | — | Jun 23, 1989 | |
| METHYLDOPA | PLIVA | ANDA 072126 | — | Jul 07, 1988 | |
| METHYLDOPA | PLIVA | ANDA 072127 | — | Jul 07, 1988 | |
| METHYLDOPA | PLIVA | ANDA 072128 | — | Jul 07, 1988 | |
| METHYLDOPA | HALSEY | ANDA 071751 | — | Mar 28, 1988 | |
| METHYLDOPA | HALSEY | ANDA 071752 | — | Mar 28, 1988 | |
| METHYLDOPA | HALSEY | ANDA 071753 | — | Mar 28, 1988 | |
| METHYLDOPA | CHARTWELL RX | ANDA 071700 | — | Mar 02, 1988 | |
| METHYLDOPA | QUAGEN | ANDA 070535 | — | Jan 02, 1987 | |
| METHYLDOPA | QUAGEN | ANDA 070536 | — | Jan 02, 1987 | |
| METHYLDOPA | QUAGEN | ANDA 070537 | — | Jan 02, 1987 | |
| METHYLDOPA | DURAMED PHARMS BARR | ANDA 071006 | — | Dec 16, 1986 | |
| METHYLDOPA | DURAMED PHARMS BARR | ANDA 071009 | — | Dec 16, 1986 | |
| METHYLDOPA | TEVA | ANDA 071105 | — | Dec 05, 1986 | |
| METHYLDOPA | TEVA | ANDA 071106 | — | Dec 05, 1986 | |
| METHYLDOPA | TEVA | ANDA 071067 | — | Dec 05, 1986 | |
| METHYLDOPA | SUN PHARM INDUSTRIES | ANDA 070073 | — | Oct 09, 1986 | |
| METHYLDOPA | SUN PHARM INDUSTRIES | ANDA 070060 | — | Oct 09, 1986 | |
| METHYLDOPA | SUN PHARM INDUSTRIES | ANDA 070074 | — | Oct 09, 1986 | |
| METHYLDOPA | WATSON LABS | ANDA 070703 | — | Jun 06, 1986 | |
| METHYLDOPA | WATSON LABS | ANDA 070625 | — | Jun 06, 1986 | |
| METHYLDOPA | ROXANE | ANDA 070192 | — | Apr 25, 1986 | |
| METHYLDOPA | ROXANE | ANDA 070193 | — | Apr 25, 1986 | |
| METHYLDOPA | ROXANE | ANDA 070194 | — | Apr 25, 1986 | |
| METHYLDOPA | PARKE DAVIS | ANDA 070331 | — | Apr 15, 1986 | |
| METHYLDOPA | PARKE DAVIS | ANDA 070332 | — | Apr 15, 1986 | |
| METHYLDOPA | PARKE DAVIS | ANDA 070333 | — | Apr 15, 1986 | |
| METHYLDOPA | WATSON LABS | ANDA 070245 | — | Feb 25, 1986 | |
| METHYLDOPA | WATSON LABS | ANDA 070246 | — | Feb 25, 1986 | |
| METHYLDOPA | WATSON LABS | ANDA 070247 | — | Feb 25, 1986 | |
| METHYLDOPA | HERITAGE PHARMA | ANDA 070098 | — | Feb 20, 1986 | |
| METHYLDOPA | HERITAGE PHARMA | ANDA 070343 | — | Feb 20, 1986 | |
| METHYLDOPA | PUREPAC PHARM | ANDA 070749 | — | Feb 07, 1986 | |
| METHYLDOPA | PUREPAC PHARM | ANDA 070750 | — | Feb 07, 1986 | |
| METHYLDOPA | PUREPAC PHARM | ANDA 070452 | — | Feb 07, 1986 | |
| METHYLDOPA | ACCORD HLTHCARE | ANDA 070070 | — | Oct 15, 1985 | |
| METHYLDOPA | ACCORD HLTHCARE | ANDA 070084 | — | Oct 15, 1985 | |
| METHYLDOPA | ACCORD HLTHCARE | ANDA 070085 | — | Oct 15, 1985 | |
| METHYLDOPA | WATSON LABS | ANDA 070260 | — | Jun 24, 1985 | |
| METHYLDOPA | WATSON LABS | ANDA 070261 | — | Jun 24, 1985 | |
| METHYLDOPA | WATSON LABS | ANDA 070262 | — | Jun 24, 1985 | |
| METHYLDOPA×2 | RISING | ANDA 070076 | — | Apr 18, 1985 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Methyldopa — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

